Agency: Food and Drug Administration
This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public.
Name of Committee: Clinical Pharmacology Subcommittee of the Advisory Committee for Pharmaceutical Science.
General Function of the Committee: To provide advice and recommendations
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled
``Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action.'' This draft document provides recommendations to applicants planning product quality studies to document bioavailability (BA) or